product image
Neuroendocrine Tumors (NETs)

Feb 1, 2019

For sample report, click the link below : https://www.delveinsight.com/report-store/neuroendocrine-tumors-nets-market-insights-epidemiology-and-market-forecast

Read More
product image
Snippet

Jan 2, 2018

Connection between Immune cells in the brain and Alzheimer’s disease The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorder...

Read More
product image
NOTIZIA

British scientists looking forward to treat Alzheimer’s disease through diabetes drug A group of British scientists are looking for the treatment of Alzheimer’s disease...

Read More
product image
Regeneron/Sanofi’s PD-1 drug candidate; Zika targeting drugs and vaccines developments; CMO of Achillion will leave this month; Lincoln’s anti-malarial drug

Dec 19, 2017

Regeneron/Sanofi’s PD-1 drug candidate will be tested with ISA’s HPV immunotherapy Regeneron and Sanofi’s PD-1 candidate cemiplimab is paired with Dutch biotech ISA P...

Read More
product image
Roche’s Phase 2 data; Celgene and Bluebird’s CAR-T therapy; Regeneron/Sanofi gets results; Allergan on women’s health

Dec 14, 2017

Positive Phase 2 data for Roche’s lymphoma ADC Roche’s antibody-drug conjugate for non-Hodgkin lymphoma polatuzumab has already received breakthrough designation from t...

Read More
product image
December 7 Business Cocktail

Dec 7, 2017

AbbVie aims for best-in-class psoriasis prospect The last few years have seen a wave of new biologics take the psoriasis market by storm. But a best-in-class product may st...

Read More
product image
Toll-Like Receptor Modulators: Emerging therapy for many indications

Dec 4, 2017

Toll-like receptors are a family of various related proteins that play a major role in the development and defense of plants and animals. These receptors were first discove...

Read More
product image
Ketamine to work in mice

Nov 29, 2017

Gender matters for Party drug Ketamine to work its anti-depressant activity in mice Experiments involving the popular party drug ketamine, a psychoactive recreational drug ...

Read More
product image
Biohaven’s trial ; GSK integrates; FDA Approval; Phase III trial

Nov 28, 2017

Biohaven Completes Enrollment of Rimegepant in Second Pivotal Phase 3 Clinical Trial for the treatment of Migraine Biohaven Pharmaceutical has recently announced the comple...

Read More
product image
Endometriosis : Understanding the complex disease

Mar 7, 2017

For more details click here.

Read More
product image
product image
Aurobindo takes top generic spot; Valeant unloads Dendreon; Ipsen strikes $1B deal; Takeda shells out $5.2B

Jan 12, 2017

Aurobindo takes top generic spot in Portugal with €135M deal for Generis Farmacêutica India’s Aurobindo Pharma, which has been building its presence around the world, ...

Read More
product image
Angina Pectoris : Manifestation of Coronary Artery Disease

Jan 2, 2017

Angina Pectoris is the most common and disabling cardiovascular disorder syndrome of precordial discomfort caused due to transient myocardial ischemia. A large number of pe...

Read More